Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Polymerase Chain Reaction Molecular Diagnostics Market Expected to Grow Between 2025 And 2029?
The size of the polymerase chain reaction molecular diagnostics market has experienced significant growth in recent times. The estimated projection is for it to escalate from $8.97 billion in 2024 to $9.75 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.6%. The growth experienced during the historic period is due to factors such as the rising demand for early disease diagnosis, an increase in infectious diseases, heightened awareness about genetic disorders, a rise in the adoption of point-of-care testing, and an increased incidence of chronic diseases.
The market size of the polymerase chain reaction molecular diagnostics is anticipated to witness considerable expansion in the coming years, reaching $13.54 billion in 2029 with a compound annual growth rate (CAGR) of 8.6%. This projected growth in the forecast period can be linked to the increasing incidence of cancer, rising demand for tailored medical treatment, heightened investment in molecular diagnostics, growing requirement for fast diagnostic tests, and expanding demand for non-invasive prenatal testing. Key trends projected for this forecast period consist of the maturing of diagnostic technologies, the evolution of point-of-care polymerase chain reaction systems, advances in multiplex polymerase chain reaction, the combination of polymerase chain reaction with microfluidics, and technological enhancements in digital polymerase chain reaction platforms.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24383&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Polymerase Chain Reaction Molecular Diagnostics Market?
The growth of the polymerase chain reaction molecular diagnostics market is expected to be fueled by the rising occurrences of infectious diseases. Diseases caused by harmful organisms such as bacteria, viruses, fungi, or parasites, which can be passed directly or indirectly from person to person, are increasing. The situation is being exacerbated by the arrival of antibiotic-resistant pathogens, which are tougher to manage and contain, resulting in extended illness, inflated healthcare costs, and increased risks to public health. Polymerase chain reaction (PCR) molecular diagnostics offers a more efficient way to manage infectious diseases, offering quick and precise identification of pathogens at the genetic level, which facilitates earlier diagnosis and focused treatment. This enhances healthcare outcomes by ensuring timely interventions, limiting the spread of infections, and improving patient care. For example, the Department of Health and Human Services, a government department in the U.S, reported in November 2023 that there was an 11% rise in newly reported chronic hepatitis B cases in 2022 compared to 2021. Hence, the escalating incidents of infectious diseases are propelling the growth of the polymerase chain reaction molecular diagnostics market.
Which Key Market Segments Comprise the Polymerase Chain Reaction Molecular Diagnostics Market and Drive Its Revenue Growth?
The polymerase chain reaction molecular diagnosticsmarket covered in this report is segmented –
1) By Product Type: Instrument; Reagents And Consumables; Software
2) By Technology: Real-Time Polymerase Chain Reaction; Digital Polymerase Chain Reaction; Conventional Polymerase Chain Reaction
3) By Sample Type: Blood Samples; Saliva Samples; Tissue Samples; Urine Samples
4) By Application: Infectious Disease Testing; Oncology Testing; Other Applications
5) By End-User: Hospitals; Diagnostic Laboratories; Other End Users
Subsegments:
1) By Instrument: Standard Polymerase Chain Reaction Systems; Digital Polymerase Chain Reaction Systems; Real-Time Polymerase Chain Reaction Systems
2) By Reagents And Consumables: Polymerase Chain Reaction Kits; Polymerase Chain Reaction Enzymes; Polymerase Chain Reaction Primers and Probes; Polymerase Chain Reaction Master Mix
3) By Software: Polymerase Chain Reaction Analysis Software; Data Management Software
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=24383&type=smp
Which Areas Are Leading Regions in the Polymerase Chain Reaction Molecular Diagnostics Market Expansion Across the Globe?
North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in thePolymerase Chain Reaction Molecular Diagnostics Market Over the Coming Years?
Key enterprises in the polymerase chain reaction molecular diagnostics market are dedicating their resources towards the development of technologically superior solutions like benchtop instruments to boost testing efficacy and accessibility. These benchtop instruments are compact devices, small enough to fit in a lab or on a table, but have the capabilities for extensive scientific, medical, or industrial testing and analysis. For example, in September 2024, the Germany-based biotechnology firm, QIAGEN N.V. introduced their QIAcuityDx Digital PCR System for oncology clinical testing. This system is designed for automated, no-hands-on processing, combining partitioning, thermocycling, and imaging into a single device. It provides absolute quantification of DNA and RNA with outcomes available in approximately two hours, requiring minimal hands-on time. The system can accommodate up to five detection channels simultaneously, facilitating multiplexing and continuous nanoplate loading. It also includes both validated and flexible research modes, making it suitable for varied clinical and laboratory requirements.
View the full report here:
How Is the Polymerase Chain Reaction Molecular Diagnostics Market Conceptually Defined?
Polymerase chain reaction (PCR) molecular diagnostics is a laboratory technique used to amplify and analyze specific deoxyribonucleic acid or ribonucleic acid sequences in a sample. Its main purpose is to detect the presence of specific genetic material, enabling the identification of pathogens, genetic disorders, or mutations. It is widely used in medical diagnostics for detecting infectious diseases, genetic disorders, and cancer markers with high sensitivity and accuracy.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24383
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model